3min chapter

The MATTER Health Podcast cover image

Tales from the Trenches™ with Sheila Mikhail, Co-founder and CEO of AskBio

The MATTER Health Podcast

CHAPTER

The FDA's Reluctance to Develop a Drug in the Clinic

The FDA was being cautious because there had been a big red flag and they wanted to make sure, especially going into children that all of the precautions were taken. So in no way do I want to sound harsh to the FDA. It was just necessary growing pains considering this was almost like coming out of, you know, small academic centers. They weren't coming from big pharma with all of the sophistication. And so the field has matured a lot over the last 20 years.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode